FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely ophthalmology, and is intended to reduce increased intraocular pressure. An aqueous ophthalmic pharmaceutical composition for reducing intraocular pressure includes tafluprost, disodium edetate, pH regulators, hexite, macrogol, boric acid, trometamol. The components are used in the stated quantities.
EFFECT: use of the invention provides an ophthalmic composition that is stable in contact with all types of resinous (polymer) surfaces, and also makes it possible to increase the quality of liquid dosage forms by eliminating the problems of adsorption of tafluprost on the walls of the primary packaging during storage.
9 cl, 7 dwg, 32 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITIONS CONTAINING PROSTAMIDE RELEASING NITROGEN OXIDE | 2019 |
|
RU2781022C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS, CONTAINING BORATE-POLYOL COMPLEXES | 2010 |
|
RU2563125C2 |
| OPHTHALMIC GEL BIMATOPROST, WHICH IS APPLIED IN FORM OF DROPS | 2016 |
|
RU2698456C2 |
| ANESTHETIC COMPOSITION AND METHOD OF EYE ANESTHETIZATION | 2020 |
|
RU2812900C2 |
| COMPOSITION IN THE FORM OF EYE DROPS TO DECREASE INTRAOCULAR PRESSURE | 2017 |
|
RU2772230C2 |
| EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
| KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATMENT OR PREVENTION OF OCULAR PAIN | 2009 |
|
RU2431469C1 |
| MEDICATION FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGICAL DISEASES | 2008 |
|
RU2359658C1 |
| STORAGE OF STABLE PREPARATION OF PROSTAGLANDIN | 2010 |
|
RU2482851C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES | 2009 |
|
RU2477631C2 |
